Published: 2021-04-15 14:31
Last Updated: 2021-05-06 12:47
Wednesday, the Russian Gamaleya research institute, which is the developer of Russia's “Sputnik V” COVID-19 vaccine said its jab does not cause blood clots, a potential side effect that has disrupted rollouts in several Western countries.
"A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine showed that there were no cases of cerebral venous sinus thrombosis," it said in a statement.
Russian President Vladimir Putin announced Wednesday that he had received the second dose of the coronavirus vaccine. However, it was not mentioned which vaccine of Russia's three vaccines (EpiVacCorona, CoviVac or Sputnik V) he received.
Tuesday, US regulators recommended halting use of the Johnson & Johnson vaccine due to blood clotting concerns. This came after one person out of nearly seven million Americans died from a rare type of clot in the brain after receiving the vaccine.
Denmark Wednesday became the first country to stop using AstraZeneca’s coronavirus vaccine after reports of rare but serious cases of blood clots among those that had received the vaccine.
Like the Johnson & Johnson and AstraZeneca vaccines, Sputnik V uses adapted strains of the adenovirus that causes the common cold.